Aikium
PrivateLast Round
Grant
Jun 23, 2025
Total Funding Raised
$1.6M
Company Overview
Aikium is a biotechnology company that develops protein therapeutics for neuro-inflammation and oncology by leveraging breakthroughs in synthetic biology and deep learning to develop proprietary non-antibody scaffold proteins.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, ML Platforms, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aikium Comparables
Compare Aikium with similar companies based on industry and business-model similarity.
Aikium Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 23, 2025 | ||||
| Pre Seed | Nov 15, 2024 |
Key People
Founding team and executive leadership
Aikium Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 3i Partners | Pre Seed |
| Bantam Group | Pre Seed |
| Civilization Ventures | Pre Seed |
| Half Court Ventures | Pre Seed |
| Fellows Fund | Pre Seed |
Aikium Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Aikium's valuation, stock price, and market status.